US Patent Issued to Institute for Cancer Research, University of Kansas on Nov. 11 for "Compositions and methods for modulation of antibody activity" (Pennsylvania Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,637, issued on Nov. 11, was assigned to Institute for Cancer Research (Philadelphia) and University of Kansas (Lawrence, Kan.).

"Compositions and methods for modulation of antibody activity" was invented by John Karanicolas (Philadelphia), Jittasak Khowsathit (Philadelphia) and Daniel Pushparaju Yeggoni (Philadelphia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods for modulating antibody activity are disclosed."

The patent was filed on April 29, 2020, under Application No. 17/600,831.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOF...